Korea roundup: Alteogen, Celltrion lead biotech deals

AI Briefing

• – Alteogen signed $579 million deal with Biogen, Celltrion boosted pipeline with $137.45 million deal, SK Chemicals expands with J2H Biotech, Yatiri Bio signs global option agreement with Oscotec.